Scientific Advisory Board

David Allen Bushinsky, M.D. Professor of Medicine and of Pharmacology and Physiology, University of Rochester School of Medicine, and Chief, Nephrology Division, University of Rochester Medical Center
John Cunningham, D.M. Professor of Nephrology, UCL Medical School, London; Consultant Nephrologist, Royal Free Hospital, London, and The London Clinic; Physician, King Edward VII Hospital, London; Head of the Medical Household to HM the Queen; and Physician to the Queen.
Bess Dawson-Hughes, M.D. Professor of Medicine, Tufts University School of Medicine, and Senior Scientist and Director, Bone Metabolism Laboratory Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
Glenville Jones, Ph.D. Head of Biochemistry Department, Professor of Biochemistry & Medicine, Queen's University
Kevin Martin, M.D. Director of Research, Division of Nephrology, St. Louis University School of Medicine
L. Darryl Quarles, M.D. Director of Division of Nephrology, and Associate Dean for Research, University of Tennessee Health Science Center.
Isidro Salusky, M.D. Professor of Pediatric Medicine, David Geffen School of Medicine, and Director of Clinical Research Center, UCLA School of Medicine
Stuart Sprague, D.O. Chief, Division of Nephrology and Hypertension, North Shore University Health System, and Professor of Medicine, University of Chicago Pritzker School of Medicine
Myles Wolf, MD, MMSc Chief of Division of Nephrology, Duke University School of Medicine

Myles Wolf, MD, MMSc

Chief of Division of Nephrology, Duke University School of Medicine

Dr. Wolf received his medical degree from the State University School of New York Downstate in Brooklyn, New York.  He completed internal medicine training at the Massachusetts General Hospital and a nephrology fellowship at the Massachusetts General Hospital and the Brigham and Women's Hospital in Boston, Massachusetts.  During his research fellowship training in nephrology, Dr. Wolf obtained a Masters of Medical Sciences in Clinical and Physiological Investigation from Harvard Medical School.

The focus of Dr. Wolf's research is disordered mineral metabolism across the spectrum of chronic kidney disease, including dialysis, kidney transplantation and earlier stages.  His research has been published in leading general medicine and subspecialty journals including the New England Journal of Medicine, the Journal of the American Medical Association, the Journal of Clinical Investigation, Circulation, Journal of the American Society of Nephrology and Kidney International, among others.  His primary contributions have been in the area of hormonal regulation of phosphorus and vitamin D homeostasis.  He has helped to characterize the physiological role of fibroblast growth factor 23 (FGF23) in health and in chronic kidney disease and the impact of elevated FGF23 levels on adverse clinical outcomes in patients with kidney disease. He serves on the editorial boards for Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology and Seminars in Nephrology, and as an ad hoc peer reviewer for several other journals. In 2010, he was elected to the American Society of Clinical Investigation. 

 
     
     
 
   

© 2017 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use